Cargando…

Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

KEY MESSAGES: Currently, tumour budding is a poor prognosis for various solid tumours, also in breast cancer. Tumour budding is based on epithelial-mesenchymal transition and tumour microenvironment factors and is presumed to be an early step in the metastatic process. Breast cancer tumour budding s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ting, Bao, Hui, Meng, Yu-hua, Zhu, Jian-lin, Chu, Xiao-dong, Chu, Xiao-li, Pan, Jing-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103277/ https://www.ncbi.nlm.nih.gov/pubmed/35535687 http://dx.doi.org/10.1080/07853890.2022.2070272

Ejemplares similares

Strategies for five tumour markers in the screening and diagnosis of female breast cancer
por: Luo, Jun, et al.
Publicado: (2023)

Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
por: Li, Jing, et al.
Publicado: (2022)

High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer
por: Zhan, Zhao, et al.
Publicado: (2022)

ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer
por: Li, Jingtong, et al.
Publicado: (2022)

Application status and future prospects of the PDX model in lung cancer
por: Liu, Wei, et al.
Publicado: (2023)

A Protocol for Cancer-Related Mutation Detection on Exosomal DNA in Clinical Application
por: Wang, Zhe-Ying, et al.
Publicado: (2020)

Ultrasound radiomics in personalized breast management: Current status and future prospects
por: Gu, Jionghui, et al.
Publicado: (2022)

The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects
por: Lu, Xingjia, et al.
Publicado: (2022)

Tumor Budding in Upper Gastrointestinal Carcinomas
por: Koelzer, Viktor H., et al.
Publicado: (2014)

Establishment and Clinical Application of an Artificial Intelligence Diagnostic Platform for Identifying Rectal Cancer Tumor Budding
por: Liu, Shanglong, et al.
Publicado: (2021)

Mapping Intellectual Structures and Research Hotspots of Triple Negative Breast Cancer: A Bibliometric Analysis
por: Hao, Kai-jun, et al.
Publicado: (2022)

Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
por: Xiang, Zhenxian, et al.
Publicado: (2022)

Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis
por: Thakur, Nishant, et al.
Publicado: (2022)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Diagnostic value of Kaiser score combined with breast vascular assessment from breast MRI for the characterization of breast lesions
por: Zhou, Xin-zhu, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
por: Thomas, Remy, et al.
Publicado: (2021)

Tumor budding in gastric cancer
por: Xiao, Shuo-Meng, et al.
Publicado: (2023)

Application and evaluation of hydrodissection in microwave ablation of liver tumours in difficult locations
por: Song, Yuan, et al.
Publicado: (2023)

Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2018)

Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
por: Maffeis, Valeria, et al.
Publicado: (2019)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
por: Chang, Ying-Jun, et al.
Publicado: (2021)

Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
por: Ku, Ki Man, et al.
Publicado: (2022)

Effect of bladder filling status on positioning errors in post-hysterectomy cervical cancer radiotherapy
por: Ge, Bin-Bin, et al.
Publicado: (2023)

Corrigendum: Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2021)

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study
por: Yang, Hua, et al.
Publicado: (2021)

The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer
por: Gujam, F J A, et al.
Publicado: (2015)

Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
por: Kairaluoma, Valtteri, et al.
Publicado: (2020)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3
por: Dai, Yue-chu, et al.
Publicado: (2021)

ABO blood groups and liver cancer: prospective results from an HBsAg cohort study
por: Lu, Ling-Ling, et al.
Publicado: (2021)

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer
por: Zhang, Lianmei, et al.
Publicado: (2023)

Myelin-associated proteins are potential diagnostic markers in patients with primary brain tumour
por: Koper-Lenkiewicz, Olga M., et al.
Publicado: (2021)

Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects
por: Lin, Xinrong, et al.
Publicado: (2021)

Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Recurrent Phyllodes Tumour of the Breast Transforming to a Fibrosarcoma
por: Jabeen, Dua, et al.
Publicado: (2020)

Development and validation of a nomogram to predict overall survival in patients with incidental gallbladder cancer: A retrospective cohort study
por: Xie, Zhi-Hua, et al.
Publicado: (2023)

Tumor budding is a potential histopathological marker in the prognosis of oral squamous cell carcinoma: Current status and future prospects
por: Kale, Alka D, et al.
Publicado: (2019)

Whole-Transcriptome Analysis of Differentially Expressed Genes in the Vegetative Buds, Floral Buds and Buds of Chrysanthemum morifolium
por: Liu, Hua, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j98d954ttqa3sdpnqcji4epkpg